Compared with other glomerulopathy groups, the DN group had a higher prevalence of DR and SBP, while the IMN group had a higher UTP level and anti-PLA2R antibody positive rate, but lower ALB, BUN, Scr, and eGFR (P < 0.05). This evidence concerns the gene ALB and lipoprotein glomerulopathy.